Immunotoxicologic testing of drug candidates and environmental contaminants is of growing importance. Cutaneous delayed type hypersensitivity (OTH) is a convenient way of testing immune function in vivo. However, OTH testing must not interfere with interpretation of other relevant parameters. We have evaluated the effects of sensitization and challenge with dinitrochlorobenzene (ONCB) on clinical parameters routinely evaluated in toxicity testing and on lectin-mediated blastogenesis. Female cynomolgus monkeys were sensitized to ONCB with 4 daily applications of ONCB in acetone to the skin of the axilla. Fifteen days later, the monkeys were challenged for OTH by applying ONCB to the antecubital skin. Skin fold thickness was measured and the macroscopic appearance of the challenge site was scored 24 and 48 hr after challenge. All 5 monkeys were successfully sensitized to ONCB. There was a significant increase in the mean skin fold thickness (compared to pre-challenge thickness) of 2 mm at 24 hr and 1 mm at 48 hr (p < 0.001). The clinical score of the challenge site was also increased. Histologic examination of the sensitization and challenge sites from a second group of monkeys exposed to ONCB in an identical manner showed the perivascular inflammatory cell infiltrate typical of OTH. Evaluation of hematologic parameters at days 7, 14, and 21 revealed no change in the erythron at any interval and a mild decrease in total WBC, neutrophil and lymphocyte counts on day 7 in 4/5 monkeys. The WBC parameters remained within the normal range and returned to pre-sensitization values at the later intervals. Clinical biochemical parameters related to liver and kidney function were evaluated at the same intervals and no changes were found. The blastogenic response of peripheral blood leukocytes to concanavalin A, phytohemagglutinin and pokeweed mitogen was mildly but not significantly decreased at day 7 but not on day 14 or 21. This study has shown that sensitization to ONCB in cynomolgus monkeys is a reliable means of evoking a OTH response which is quantifiable. It has also shown that sensitization and challenge with ONCB can be incorporated into toxicity studies without confounding interpretation of other toxicity data.
INTRODUCTION
The immune response can be divided into 2 arms; a humoral arm, whose principal effectors are immunoglobulin producing B lymphocytes and plasma cells, and a cellular arm whose principal effectors are T-lymphocytes and macrophages (7) . Cell-mediated immunity (CMI) is responsible for many aspects of host defense, especially defense against viral, opportunistic and intracellular pathogens (23) . CMI also mediates graft rejection and graft versus host disease (6) .
Mounting a successful CMI response requires a complex interaction of many types of immune cells, especially CD4+ T-lymphocytes (T-helper cells)and major histocompatibility complex class II (MHC 643 Time line for ONCS Sensitization/Challenge 
The procedures conducted on a given day are shown adjacent to the day of study. Only the days on which a special procedure was conducted are shown. class II) bearing antigen-presenting cells (9) . Because of growing interest in the immune system as a desired target for therapeutic intervention and as a potential target for adverse effectsin toxicity studies, we wished to define a method to study CMI in primates. Also, since there is considerable homology between CD4 and MHC Class II of humans and monkeys (5, 12, 13, 16, 18, 24) we chose cynomolgus monkeys as the subjects for our study. Since we wished to incorporate testing CMI responses into routine toxicity testing, it was necessary to exclude experimental protocols which could induce significant adverse effects in their own right, such as those which rely on commonly used adjuvants (4) . Our selection of a model system was also limited by our desire to study effects on the induction of CMI as well as any effects on the response of previously sensitized animals. This ruled out using any of the common models which rely on indigenous bacterial or fungal antigens, e.g., Candida (10) . Finally, the model had to be reproducible and had to provide a quantifiable measure of CMI. Many antigens which work well in humans give poorly quantifiable results in monkeys (14) . To fulfill all ofthese criteria, we chose skin sensitization to dinitrochlorobenzene (DNCB) as our model system. DNCB has been used extensively in experimental rodents (2, 21) and in humans (1, 17) , to induce and evoke CMI and it has been demonstrated that responses to DNCB are blunted in immunosuppressed animals (25) . Furthermore, DNCB has been used previously in the cynomolgus monkeys (8) .
The results of this study have shown that DNCB reliably sensitizes cynomolgus monkeys for CMI and evokes a quantifiable response. They have also shown that DNCB does not effect parameters commonly evaluated in toxicity studies.
MATERIALS AND METHODS Animals
Five wild caught female cynomolgus monkeys (Macaca fascicularisi supplied by Hazelton Research Animals, Vienna, VA, were used in this study. They were housed individually in stainless steel cages, were provided water ad libitum, and fed twice a day. The monkeys were restrained with collars for all manipulations and were never anesthetized. All monkeys were challenged with DNCB to determine ifany had been "spontaneously" sensitized to DNCB prior to experimental sensitization.
DNCB Sensitization and Challenge
The monkeys were sensitized to DNCB (Aldrich Chemical Company, St. Louis, MO) using the method described by Ferraresi et al (8) . The study design is outlined in Fig. I . The axillary region ofeach arm was shaved and then painted with a 0.5% solution of DNCB in acetone. DNCB (0.5 ml) was applied by pipet to each arm for 4 consecutive days.
To challenge for a CMI response, 0.05 ml of a 0.6% solution of DNCB in acetone was applied by pipet to the shaved antecubital skin ofthe right arm on day -3 (pre-sensitization) and on days 21 and 35. Acetone (0.05 ml) was applied to the antecubital skin of the left arm as a specificity control on these same days. • Skinfold thickness of the antecubital skin was measured prior to and 24 and 48 hr after application of 0.05 ml acetone (left arm) or 0.05 ml 0.6% DNCB in acetone (right arm).
ba skinfold thickness = measurement prior to application -measurement after application.
c Not significantly different from change due to acetone (2 tailed r-test), Induration ofthe challenge sites was evaluated by measuring skin fold thickness with a constant pressure caliper (Starret, Athol, MA) prior to applying DNCB and at 24 and 48 hr. The challenge site was also scored for macroscopic appearance. Erythema, contour, induration, texture and appearance of superficiallayers were scored, compared to adjacent skin. A value of + I was added for each affected parameter, with +5 being the highest possible score.
Clinical Pathology and Immunology
Blood samples were collected on day I (pre-sensitization) and on days 7, 14, and 21. The following parameters were measured using routine methods. Hematology: Hemoglobin, PCV, RBC, MCV, MCH, MCHC, WBC, differential and platelet count. Clinical Chemistry: Urea nitrogen; creatinine; alkaline phosphatase (Alkp); aspartate aminotransferase (AST); alanine aminotransferase (ALT); and total protein.
Lectin-mediated blastogenesis was evaluated at the same intervals using a modification ofthe whole blood method for phytohemagglutinin (PHA) of Humber and Hetherington (11) • Skinfold thickness of the antecubital skin was measured prior to and 24 and 48 hr after application of 0.05 ml acetone or 0.05 ml 0.6% DNCB in acetone. b a skinfold thickness = measurement prior to application -measurement after application.
'Statistically different from corresponding change due to acetone p < 0.00 I (two tailed r-test).
with 1 mCi 3H-thymidine (2 Ci/mmole, New England Nuclear, Boston, MA) for the final 18 hr of incubation. The cells were then collected on glass fiber filters using a PHD cell harvester (Cambridge Technologies, Cambridge, MA) and cell-associated radioactivity measured by liquid scintillation counting. Data are reported as mean cpm with mitogen minus mean cpm without mitogen per 10 3 lymphocytes. The number of lymphocytes was calculated from the total WBC and differential counts for each sample.
Histopathology
Since the monkeys described in this report were not sacrificed, tissues were not available for histopathological examination. The histopathological findings described herein are from another group of 8 monkeys that were sensitized and challenged with DNCB in an identical manner. (These monkeys served as vehicle control animals in another toxicity study). They were challenged on day 21 and sacrificed on day 23. The skin sensitization (axilla) and antecubital challenge sites and the axillary lymph nodes were fixed in 10% phosphate-buffered formalin, embedded in paraffin, sectioned at 5 Ilm and routinely stained with hematoxylin and eosin (H&E).
RESULTS

Skin Sensitization
The results of the skin fold thickness measurements made prior to sensitization to DNCB are shown in Table I . The mean thickness of the antecubital skin of the monkeys in this study prior to application of acetone or DNCB was 1.23 ± 0.09 in the skin of the upper arm except for a yellow mm (±SD). As shown in the table, the single ap-discoloration of the skin and mild erythema (obplication ofDNCB did not cause a significant change served on day 2). After the second application, one in the group mean skin fold thickness compared to monkey (N90) showed peeling ofthe cornified layers acetone either at 24 or 48 hr after application. This at the site of sensitization. After the 3rd and/or 4th indicates that none of the animals had been previ-application of the sensitizing dose of DNCB, all 5 ously sensitized to DNCB. monkeys showed sloughing of the superficial layers Application ofthe first sensitizing dose ofDNCB of the skin. In 3 of the monkeys, the sensitization (0.5 ml, 0.5% DNCB in acetone) caused little change sites were highly irritated and had areas of hemor-Animal number N78 N80 N90 N91 N95 .' .'
." ."
," " .,.,.,.,.,. rhagic crusting. The sensitization sites were left uncovered and healed uneventfully over the next 7 to 11 days in all monkeys.
The results of the DNCB and acetone challenge are shown in Table II . Challenge with DNCB resulted in a significant change in skin fold thickness in all 5 monkeys. The mean absolute value for skin fold thickness was 3.2 ± 1.0 mm at 24 hr postchallenge and 2.5 ± 1.0 mm at 48 hr. As was seen prior to sensitization, acetone had no effect on skin fold thickness.
The DNCB challenge sites were also evaluated clinically and scored for erythema, induration texture, contour and condition of the superficial layers ofthe epithelium. As shown in Table II , all monkeys also responded macroscopically to DNCB.
The monkeys received a second challenge with DNCB on study day 35. Again, all monkeys re- sponded to DNCB with a significant change in skin fold thickness and clinical score (data not shown).
Body Weight
Body weight for the monkeys in this study was recorded weekly. There were minimal changes in body weight which were of no toxicologic significance.
Clinical Pathology
The results of the clinical chemistry assays are shown in Table III . There were no changes of toxicologic significance in any animal for the parameters evaluated.
The results ofhematologic evaluations are shown in Table IV . The WBC, neutrophil, eosinophil and lymphocyte counts were elevated for monkey N80 at all intervals and the WBC, neutrophil and lymphocyte counts were decreased for monkeys N78, N80, N90 and N95 on day 7 compared to day I.
Lectin-Mediated Blastogenesis
The results of the blastogenesis assays are shown in Fig. 2 . All monkeys responded to the 3 mitogens in a dose responsive manner but there was considerable inter-animal and day-to-day variation. Despite the variation, there was discemable decreased reactivity for 4/5 monkeys for 2 or 3 mitogens on day 7. This decrease is particularly evident in the response to PWM. Although these changes were not statistically significant (Wilcoxon multicomparison test), the consistency of the decreases suggests that this is a bona fide effect of repeated application of DNCB to the skin. There were no other consistent changes in responsiveness to the mitogens during this study.
Histopathology
Macroscopically, no changes were observed at the skin sensitization site in 4 of 8 monkeys. The other 4 showed minimal changes which varied from the presence of scales to erythematous wheals. The axillary lymph nodes were slightly enlarged in the majority ofanimals. With the exception ofthe presence of scales in one monkey, no other gross lesions were observed at the skin challenge sites.
Microscopically, the skin sensitization sites showed minimal acanthosis and parakeratosis, minimal hyperplastic response of the basal cell layer, a minimal loss of epidermal appendages, and a minimal to mild mixed cell, predominantly mononuclear, perivascular inflammatory cell infiltrate. One monkey showed focal acute ulcerative dermatitis and another showed focal pustular dermatitis.
Microscopic examination of the antecubital challenge sites revealed similar changes. Perivascular inflammatory infiltrates were prominent ( Fig. 3 ) but the epidermal changes were milder. Additionally the skin of2/8 showed minimal multifocal acantholysis.
Microscopic examination of the axillary lymph nodes showed prominent germinal centers accompanied by perifollicular lymphocyte proliferation (Fig. 4 ).
DISCUSSION
This study has shown that DNCB is a reproducible and reliable inducer of cutaneous delayed type hypersensitivity in the cynomolgus monkey. The data also suggests that DNCB induces a true DTH response and not simple chemical irritation. This conclusion is supported by the lack of reaction to DNCB prior to sensitization, the lack of reaction to acetone and the histopathologic finding of perivascular cuffing at the challenge sites and reactive follicular hyperplasia in the axillary lymph nodes.
DNCB is believed to act as a sensitizer for DTH by penetrating the skin and then reacting with proteins in the dermis and extracellular fluid. This reaction results in the formation of dinitrophenylated proteins which are recognized as foreign by the immune system (20) . It has been shown previously that DNCB readily penetrates the skin of humans and monkeys (3) and that followingapplication ofDNCB, dinitrophenylated proteins can be detected in draining lymph nodes (19) . Because DNCB reacts with structural as well as soluble proteins, it acts as a persistent antigen which favors formation of cellular as opposed to humoral immunity.
In this study, we also determined if sensitization with DNCB would cause any systemic effectswhich would confound interpretation of data in toxicity testing. No effect was found on clinical biochemical indicators of kidney and liver function , or on erythrocyte parameters. A mild decrease in WBC, lymphocytes and neutrophils was observed in 4 of 5 animals on day 7. In none of these monkeys, however, were the leukocyte counts below the normal range for female cynomolgus monkeys. These changes in leukocyte count probably reflect a re-Sponseto the irritation and inflammation caused by the sensitizing doses ofDNCB. The skin ofthe upper arms of several of the monkeys was excoriated and slOUghing of the superficial epidermal layers was noted. However , the sensitization sites healed uneventfully and presented no long-term problem to the monke ys.
We also examined the ability of the animals to respond to lectins. Con A and PHA are mitogenic for T-lymphocytes (22) and PWM for B lymphocytes (15) in monkeys and provide an index of the cell's ability to respond to a non-specific stimulus. Other than a mild and not statistically significant suppression on day 7 in 4/5 monkeys, there was no consistent effect on lectin-mediated blastogenesis. Although the decreases were not statistically significant, they were consistent across the animals and correlate with the decrease in circulatory lymphocytes seen on day 7 in all monkeys. The mechanism of these changes is not known. However, on day 7 the sensitization sites were highly inflammed and the skin was broken and crusted over. It is possible that the changes in response to mitogens and the decreased lymphocytes is secondary to this inflammation and is not a direct effecf of DNCB.
In conclusion, this study has shown that: 1), four applications of 0.5 ml 0.5% DNCB in acetone reliably sensitizes cynomolgus monkeys for DTH which is quantifiable and lasts for at least 29 days after sensitization, and 2) sensitization with DNCB causes no adverse systemic effectswhich would confound interpretation of toxicity data.
